Profile
Laura van't Veer is the founder.
Founded Agendia NV in 2003 as Chief Research Officer.
Founded Agendia, Inc. in 2003 as Chief Research Officer.
Current job at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh as Principal.
Former job at The University of California, San Francisco as Professor.
Laura van't Veer active positions
| Companies | Position | Start |
|---|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Founder | 2010-01-28 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Founder | 2002-12-31 |
Former positions of Laura van't Veer
| Companies | Position | End |
|---|---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 2020-01-07 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
- Stock Market
- Insiders
- Laura van't Veer
















